NEW YORK, Oct. 11, 2021 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by
Flexion Therapeutics, Inc. (NASDAQ: FLXN) and its board of
directors concerning the proposed acquisition of the company by
Pacira BioSciences, Inc. (NASDAQ: PCRX). Stockholders will receive
$8.50 and one contingent value right
worth up to $8.00 for each share of
Flexion Therapeutics stock that they hold. The transaction is
expected to close in the fourth quarter of 2021.
If you are a stockholder of Flexion Therapeutics, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/flxn/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-flexion-therapeutics-inc-301397278.html
SOURCE Rowley Law PLLC
